Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis and interferon beta-1b, past, present and future

Reinhard Horowski1

  • 1Schering AG, Medical Scientific Relations, Muellerstrasse 176, D-13342 Berlin, Germany. reinhard.horowski@schering.de

Clinical Neurology and Neurosurgery
|July 20, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures.

Journal of neural transmission (Vienna, Austria : 1996)·2020
Same author

Paul Ehrlich, founder of Medicinal Chemistry, has used blotting paper for an early form of paper chromatography.

Journal of neural transmission (Vienna, Austria : 1996)·2013
Same author

Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A receptors.

The Journal of pharmacology and experimental therapeutics·2007
Same author

Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes.

Naunyn-Schmiedeberg's archives of pharmacology·2007
Same author

Agonism at 5-HT2B receptors is not a class effect of the ergolines.

European journal of pharmacology·2005